Regulus Therapeutics Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (34)

Latest Posts

About This Stock More About This Stock
Regulus Therapeutics Dips After Warning Of Drug Development Delays
Article By: The Fly
Wednesday, November 2, 2016 4:49 PM EDT
Shares of Regulus Therapeutics fell Wednesday after the company reported third-quarter results, which included news of several delays in its drug development efforts.
In this article: RGLS
Read
Regulus Therapeutics Receives FDA Clinical Hold For Hepatitis C Drug
Article By: Terry Chrisomalis
Monday, June 27, 2016 11:35 PM EDT
Shares of Regulus Therapeutics tanked by 60% after the company announced that the FDA has placed a clinical hold on its Hepatitis C drug candidate.
In this article: RGLS
Read
Regulus Receives Final Milestone Payment From Biogen For Multiple Sclerosis Development
Article By: Terry Chrisomalis
Wednesday, October 28, 2015 1:46 PM EDT
Today Regulus Therapeutics (RGLS) announced that it has received its fourth and final milestone payment from Biogen (BIIB).
In this article: RGLS, BIIB
Read
Morning Call For April 8, 2015
Article By: Jim Van Meerten
Wednesday, April 8, 2015 8:53 AM EDT
June E-mini S&Ps this morning are little changed as the market awaits today's FOMC meeting minutes. The Euro Stoxx 50 index is down -0.39% after yesterday's rally.
In this article: RAD, DIS, KMI, NRZ, PLAY, RGLS, AZN, OHRP, PNR
Read
Regulus And AstraZeneca To Advance Big Potential NASH Drug
Article By: Terry Chrisomalis
Tuesday, April 7, 2015 7:24 PM EDT
AstraZeneca okays go-ahead for microRNA therapeutics in additional area.
In this article: RGLS, AZN, ICPT, CNAT, LJPC
Read

Latest Tweets for $RGLS

No tweets yet!

PARTNER HEADLINES